Partner Headlines - ESRX

  1. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  2. UnitedHealth Earnings Drop on ObamaCare, Medicare Cuts

    IBD
  3. Funds Buying UnitedHealth: Stunning Div Growth

    YCharts
  4. House Probe Of Gilead's Sovaldi Price Hits Biotechs

    IBD
  5. Gilead Pricing Probed By House; Biotech Stocks Drop

    IBD
  6. Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI

    GuruFocus
  7. Google, Ebay: Why A Top Mutual Fund Likes Them

    IBD
  8. Top 4 Large-Cap Stocks In The Health Care Plans Industry With ...

    Benzinga
  9. UPDATE: Morgan Stanley Reiterates on Express Scripts Following ...

    Benzinga
  10. Stock Market Erases Gains, Closes With Losses

    IBD
  11. Stocks Advance In Big Trade; Spirit, Priceline Climb

    IBD
  12. EXPRESS SCRIPTS

    IBD
  13. Earnings Scheduled For February 20, 2014

    Benzinga
  14. Morgan Stanley Feels Confident About Express Scripts Holding ...

    Benzinga
  15. Revenue Growth + Sane Valuation: Making A List

    YCharts
  16. It's Time to Follow Chris Davis and Buy Laboratory Corp

    GuruFocus
  17. Double Downside Protection: Moat + Value Pricing

    YCharts
  18. Express Scripts Names Cathy R. Smith CFO

    Benzinga
  19. Investors Stick With Health Care Stocks

    FoxBusiness
  20. McKesson, Cardinal, Amerisource Up Drug-Dealing Ante

    IBD
  21. Walgreen Hurt By Generic Drug Slowdown, Sees '14 Lift

    IBD
  22. S&P Stocks Hitting New Highs

    FoxBusiness
  23. Gilead's Next Hepatitis C Drug A Hit In Trials

    IBD
  24. UPDATE: Morgan Stanley Removes PT on Express Scripts on Management ...

    Benzinga
  25. Walgreen, Rite Aid To Get Drugstore Earnings Checkups

    IBD
  26. UPDATE: Morgan Stanley Reiterates on Express Scripts on Potential ...

    Benzinga
  27. RainTree Oncology Services Announces Distribution Agreement with ...

    Benzinga
  28. Gilead knocked on drug price

    IBD
  29. Gilead HCV Drug May Face Price War; Rival AbbVie Up

    IBD
  30. Health Care ETFs After Obamacare (IHF, XLV, UNH, ESRX)

    Benzinga
  31. RT Oncology Services Joins Express Scripts Pharmacy Network

    Benzinga
  32. ETFs to Buy During Market Pullback (FDN, IHF, GOOG, AMZN, UNH)

    Benzinga
  33. Warrior Capital's Major Sells in Review - VistaPrint, Google, ...

    GuruFocus
  34. Walgreen Takes Some Steps In New Direction

    IBD
  35. UPDATE: Deutsche Bank Initiates Coverage on Express Scripts Holding ...

    Benzinga
  36. Big Surprise While Hunting Bargains: Uncle Warren

    YCharts
  37. Stocks Rise In Mixed Trade; Deckers Outdoor Leaps On Q3 Win

    IBD
  38. Benzinga's Top #PreMarket Losers

    Benzinga
  39. Scott Black's Top 5 New Stock Buys

    GuruFocus
  40. Scott Black's Delphi Management Top 5 New Stock Buys

    GuruFocus
  41. Earnings Expectations For The Week Of October 21: The Crunch ...

    Benzinga
  42. Viagra, No Levitra: Espress Scirpts’ Ix-Nay List

    YCharts
  43. Catamaran, Express Scripts May Get ObamaCare Boost

    IBD
  44. Catamaran, Express Scripts May Get ObamaCare Boost

    IBD
  45. Express Scripts Trades Far Below Moat ETF Value

    YCharts
  46. Stocks With Moats: Which Are Cheap Right Now?

    YCharts
  47. Walgreen Tops Earnings Views, Bullish On ObamaCare

    IBD
  48. Moat Logic: Up 26% YTD, Berkshire Rated Cheaper

    YCharts
  49. Walgreen To Report Q4 Ahead of ObamaCare, Expansion

    IBD
  50. Was UnitedHealth, Insurer Stock Sell-Off Premature?

    IBD
  51. PBMs shake off Walgreen news

    IBD
  52. Walgreen's Exchange Shift May Help Catamaran, PBMs

    IBD
  53. Richard Perry - Eight Sells in Second Quarter - MGIC Up 505%

    GuruFocus
  54. Express Scripts Stays One Step Ahead Of Drug Trends

    IBD
  55. Express Scripts Beats Estimates; Lifts Outlook (ESRX)

    Benzinga
  56. EXPRESS SCRIPTS

    IBD
  57. In No-Growth Era, Screening For Growth Stocks

    YCharts
  58. Benzinga Market Primer: Monday, July 29: Futures Lower On Chinese ...

    Benzinga
  59. Earnings Scheduled For July 29, 2013

    Benzinga
  60. Weekly Preview: Earnings Season Continues, Fed In Focus, Economic ...

    Benzinga
  61. 13-F Alert: Leon Cooperman's Omega Advisors Dumps Apple, Buys ...

    Benzinga
  62. McDonald's Savior Jim Skinner Chairs the Walgreen Board: If Only ...

    YCharts
  63. Catamaran PBM Business Eyeing More Fortune 500 Deals

    IBD
  64. Walgreen Up 8% YTD: But is the Sales Bounce Already Priced In?

    YCharts
  65. No Saturday Mail Delivery Won't Go Unnoticed by These Companies

    Benzinga
  66. The Top Companies Steven Romick Is Shorting

    GuruFocus
  67. Morgan Stanley Sees Possible Near-Term Increase in M&A, Unveils ...

    Benzinga
  68. Vivus up on Qsymia shipments

    IBD
  69. Vivus Stock Jumps On Latest Qsymia Shipment Numbers

    IBD
  70. Walgreen same-store sales

    IBD
  71. How Are GuruFocus Model Portfolios Faring Beside the Market in ...

    GuruFocus
  72. Worst of Self-Inflicted Mess at Walgreens Appears Over: a Bargain ...

    YCharts
  73. Pat Dorsey Discusses Fiscal Cliff and Beaten-Down Stocks Investors ...

    GuruFocus
  74. Sandy hurts Walgreen's results

    IBD
  75. Walgreen Trumps Street in 1Q Despite Softer Sales

    FoxBusiness
  76. Vivus

    IBD
  77. Industry Themes: Top Stocks Residing In Weak Groups

    IBD
  78. S&P Sees Better 2013 For Health Insurance Providers

    Benzinga
  79. CVS Guides Higher On ObamaCare, Boosts Dividend

    IBD
  80. A Visit With the S&P Dividend Aristocrats: Three Priced Attractively

    YCharts
  81. Top 5 Highly Predictable Companies with Historically Low P/B ...

    GuruFocus
  82. S&P Reiterates Bullish View on Health Care ETFs

    Benzinga
  83. UPDATE: Citigroup Upgrades Express Scripts to Buy on Valuation

    Benzinga
  84. Stocks Teeter, Wobble, Then Fall With Volume

    IBD
  85. Stocks' Slide Deepens; Catamaran, Express Scripts Drop

    IBD
  86. Ask Wedgewood Partners' David Rolfe Your Investing Question for ...

    GuruFocus
  87. IBD 50 Gets Newer Names Like Alaska Air, U.S. Silica

    IBD
  88. UPDATE: Credit Suisse Reiterates Outperform Rating, Lowers PT ...

    Benzinga
  89. CVS rises on strong earnings

    IBD
  90. Stocks Add To Gains; Vitamin Shoppe Surges

    IBD
  91. CVS, Express Scripts Beat Forecasts, Growth In Doubt

    IBD
  92. CVS Boasts Strong 3Q, Raises Outlook

    FoxBusiness
  93. Stocks Gain In Mixed Trade; Novo Nordisk Falters

    IBD
  94. Futures Edge Higher; Express Scripts, NationStar Tank

    IBD
  95. UPDATE: Jefferies Downgrades Express Scripts to Hold; Maturing ...

    Benzinga
  96. US Stock Futures Up Ahead Of Election

    Benzinga
  97. Stocks To Watch For November 6, 2012

    Benzinga
  98. Express Scripts Outlook Weak

    IBD
  99. Express Scripts Plunges After Saying 2013 Forecasts Are Too Aggressive

    Benzinga
  100. Futures Flat Monday Despite Better Economic Data from U.S.

    Benzinga
Trading Center